Katholisches Klinikum Bochum (St. Josef- und St. Elisabeth-Hospital gGmbH)

Virus-Specific T Cells and Response to Checkpoint Inhibitors in Progressive Multifocal Leukoencephalopathy (2026) Möhn N, Grote-Levi L, Bonifacius A, Tischer-Zimmermann S, Nay S, Jendretzky KF, Sassmann ML, et al. Journal article Chimeric antigen receptor T cells in treatment-refractory DAGLA antibody-associated encephalitis (2025) Hegelmaier T, Wolleschak D, Pappa V, Wickel J, Geis C, Miske R, Duscha A, et al. Journal article Comorbidities and Their Influence on Outcomes and Infectious Complications in Autoimmune Encephalitis A Multicenter Cohort Study (2025) Bohn A, Angstwurm K, Bien CG, Doppler K, Ehmke L, Havla J, Hoffmann F, et al. Journal article Complete revascularization versus culprit-lesion only PCI in patients with NSTEMI and multivessel disease – Design and rationale of the randomized COMPLETE-NSTEMI trial (2025) Feistritzer HJ, Jobs A, Zeymer U, Schneider S, Lauten P, Ferenc M, Weferling M, et al. Journal article Tackling gender in progressive supranuclear palsy: Male patients present more apathy (2025) Ye L, Greten S, Wilkens I, Wegner F, Krey L, Höllerhage M, Pötter-Nerger M, et al. Journal article Real-world experience with first- versus second-line cemiplimab for advanced basal cell carcinoma. (2025) DeTemple VK, Kaatz M, Stockfleth E, Scheel C, Angela Y, Gutzmer R, Leiter U, et al. Journal article Validation of two plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma (METAPAC): a prospective, multicentre, investigator-masked, enrichment design, phase 4 diagnostic study (2025) Mahajan UM, Oehrle B, Goni E, Strobel O, Kaiser J, Grützmann R, Werner J, et al. Journal article Epidemiological Comparative Study on Contact Sensitisations in Woodworkers With Occupational Dermatitis: Patch Test Data of the Information Network of Departments of Dermatology, 1999 to 2023 (2025) Heizmann L, Schubert S, Bauer A, Becker D, Brockow K, Dickel H, Kränke B, et al. Journal article Early Treatment With Intravenous Immunoglobulins and Outcomes of Patients With Anti-IgLON5 Disease. (2025) Grüter T, Gaig C, Crijnen YS, Titulaer MJ, Sabater L, Heidbreder A, Dargvainiene J, et al. Journal article Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomized CONKO-007 Trial (2025) Fietkau R, Ghadimi M, Grützmann R, Wittel UA, Jacobasch L, Uhl W, Croner RS, et al. Journal article